Naunyn-schmiedebergs Archives Of Pharmacology

雜志介紹

Naunyn-schmiedebergs Archives Of Pharmacology雜志介紹

《Naunyn-schmiedebergs Archives Of Pharmacology》是一本以English為主的未開放獲取國際優秀期刊，中文名稱Naunyn-schmiedebergs 藥理學檔案，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3.1，最新CiteScore 指數為6.2。

本刊近期中國學者發表的論文主要有：

• Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-beta/Smad signaling pathway

  Author: Bai, Yingwen; Wang, Lulu; Yang, Ting; Wang, Lingyun; Ge, Weihong

• Gut microbiota involved in spermatogenic function of Sancai Lianmei granules in obese mice

  Author: Xia, Yuguo; Tian, Ying; Zhou, Dongqi; Zhang, Lei; Cai, Yichen; Fu, Shunlian; Zhang, Xiaoran; Gao, Yang; Chen, Qiu; Gao, Ping

• Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer

  Author: Liu, Jinfeng; Zhang, Chang; Liu, Shuang; Wang, Xiaokang; Wu, Xiongzhi; Hao, Jian

• Pharmacokinetics of chromium-enriched yeast in rats following oral administration

  Author: Zhang, Shuang-Qing; Qin, Xian-Wu; Zhang, Yan

英文介紹

Naunyn-schmiedebergs Archives Of Pharmacology雜志英文介紹

Naunyn-Schmiedeberg's Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg's Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.